The company receives permission for an investigational study

Event 2 of 16 in How Neuralink's brain-interface research and trials unfolded

The event

May 2023

Turning point

Legal step

The company receives permission for an investigational study

Neuralink's later recruitment announcement states that the FDA awarded an investigational device exemption in May 2023. The exemption concerned conducting research, rather than commercial approval of the implant.

Neuralink Open event

Sources and context

First clinical trial open for recruitmentCompany statement · Neuralink

Sources for this event

First clinical trial open for recruitment Neuralink

Before · 31 Oct 2019
Neuralink publishes its early research platformAfter · 19 Sep 2023
The first clinical trial opens for recruitment

See it in the full timeline (16 events) →